Basic Information

Faculty

• 医学部

Concurrent Affiliation

• Graduate School of Medicine, 医学研究科 医学専攻

Academic Degree

• 博士（医学）(京都大学)

Academic Resume (Graduate Schools)

• 京都大学, 大学院医学研究科博士課程内科系専攻, 修了

Academic Resume (Undergraduate School/Majors)

• 京都大学, 医学部医学科, 卒業

ID,URL

• J-Global ID

  201401079074298269

researchmap URL

• https://researchmap.jp/7000008420

Research

Research Topics, Overview of the research

• Research Topics

  Elucidating the molecular pathogenesis of B-cell lymphomas

• Overview of the research

  We are involved in the research of elucidating the significance of genetic and epigenetic abnormalities in the pathogenesis of B-cell lymphomas.

Research Areas

• Life sciences, Hematology and oncology

Papers

• Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor-T therapy.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  British journal of haematology, 06 Jan. 2025

  Access this paper :

  
• Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Oxford medical case reports, Jan. 2025

  Access this paper :

  
• Synergistic involvement of the NZF domains of the LUBAC accessory subunits HOIL-1L and SHARPIN in the regulation of LUBAC function

  Yusuke Toda; Hiroaki Fujita; Koshiki Mino; Takuto Koyama; Seiji Matsuoka; Toshie Kaizuka; Mari Agawa; Shigeyuki Matsumoto; Akiko Idei; Momoko Nishikori; Yasushi Okuno; Hiroyuki Osada; Minoru Yoshida; Akifumi Takaori-Kondo; Kazuhiro Iwai

  Cell Death & Disease, 11 Nov. 2024

  Access this paper :

  
• Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

  Ryota Hamada; Yasuyuki Arai; Toshio Kitawaki; Naokazu Nakamura; Masanobu Murao; Michiko Matsushita; Junsuke Miyasaka; Tsugumi Asano; Tomoyasu Jo; Momoko Nishikori; Junya Kanda; Chisaki Mizumoto; Kouhei Yamashita; Ryosuke Ikeguchi; Akifumi Takaori-Kondo

  EJHaem, Dec. 2024

  Access this paper :

  
• CAR-T細胞療法後に肺動脈内のT細胞塊を認めたtriple-hit DLBCLの1例

  中村 直和; 錦織 桃子; 水本 智咲; 阪本 貴士; 諫田 淳也; 白川 康太郎; 北脇 年雄; 近藤 忠一; 山下 浩平; 高折 晃史

  臨床血液, Aug. 2022

  
• Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.

  Koji Izutsu; Kiyoshi Ando; Momoko Nishikori; Hirohiko Shibayama; Hideki Goto; Junya Kuroda; Koji Kato; Yoshitaka Imaizumi; Kisato Nosaka; Rika Sakai; Maho Abe; Seiichiro Hojo; Tadashi Nakanishi; Shinya Rai

  International journal of hematology, 23 Aug. 2024

  
• Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.

  Akio Osakada; Masakazu Fujimoto; Chiyuki Ueshima; Yo Kaku; Momoko Nishikori; Norihito Inoue; Kengo Takeuchi; Hironori Haga

  Pathology international, Sep. 2023

  
• End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.

  Koji Kato; Koji Izutsu; Momoko Nishikori; Hirohiko Shibayama; Yoshinobu Maeda; Kenichi Yoshimura; Ukihide Tateishi; Toshihiro Miyamoto; Yasufumi Matsuda; Jun Ishikawa; Shinya Rai; Tsutomu Takahashi; Takahiro Yamauchi; Itaru Matsumura; Koichi Akashi; Yuzuru Kanakura; Junji Suzumiya

  International journal of hematology, Jun. 2024

  
• Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.

  Koji Izutsu; Takahiro Kumode; Junichiro Yuda; Hirokazu Nagai; Yuko Mishima; Youko Suehiro; Kazuhito Yamamoto; Tomoaki Fujisaki; Kenji Ishitsuka; Kenichi Ishizawa; Takayuki Ikezoe; Momoko Nishikori; Daigo Akahane; Jiro Fujita; Minh Dinh; David Soong; Hidehisa Noguchi; Jeppe Klint Buchbjerg; Elena Favaro; Noriko Fukuhara

  Cancer science, Dec. 2023

  
• Methotrexate-induced subacute myelopathy: a serious but treatable complication.

  Takashi Miyoshi; Tadakazu Kondo; Momoko Nishikori; Toshio Kitawaki; Katsuya Kobayashi; Masakazu Fujimoto; Noriyoshi Yoshinaga; Satoshi Oka; Kohsuke Asagoe; Shinsaku Imashuku; Akifumi Takaori-Kondo

  Journal of clinical and experimental hematopathology : JCEH, 2023

  
• Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression (International Journal of Hematology, (2020), 111, 5, (724-732), 10.1007/s12185-019-02810-y)

  Naoki Tamura; Hirona Maeda; Momoko Nishikori; Haruyuki Fujita; Masakatsu Hishizawa; Hironori Haga; Akifumi Takaori‑Kondo

  International Journal of Hematology, 01 Aug. 2020

  
• Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Clinical and Experimental Medicine, 21 May 2024

  
• Clinical impact of CRS on prolonged hematotoxicity after CAR-T cell therapy: KyoTox a-score, a novel prediction model.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Transplantation and cellular therapy, 26 Jan. 2024

  
• KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis

  Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Naokazu Nakamura; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Bone Marrow Transplantation, 19 Dec. 2023

  
• Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy

  Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Scientific Reports, 11 Sep. 2023

  Access this paper :

  
• Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

  Fumiya Wada; Yasuyuki Arai; Tomoyasu Jo; Chisaki Mizumoto; Junya Kanda; Toshio Kitawaki; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori-Kondo

  Transplantation and Cellular Therapy, Jul. 2023

  
• Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature.

  Kensuke Nakao; Momoko Nishikori; Masakazu Fujimoto; Hiroshi Arima; Hironori Haga; Akifumi Takaori-Kondo

  Journal of clinical and experimental hematopathology : JCEH, 28 Jun. 2023

  
• T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

  Fumiya Wada; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Scientific Reports, 04 Nov. 2022

  Access this paper :

  
• Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.

  Kana Miyazaki; Rika Sakai; Noriko Iwaki; Go Yamamoto; Kayoko Murayama; Momoko Nishikori; Kazutaka Sunami; Isao Yoshida; Hiroki Yano; Naoki Takahashi; Akinao Okamoto; Saori Munemoto; Aiko Sawazaki; Youko Suehiro; Noriko Fukuhara; Atsushi Wake; Ayako Arai; Yasufumi Masaki; Kohtaro Toyama; Akihiro Yokoyama; Hiroko Tsunemine; Yuichi Hasegawa; Kenji Matsumoto; Tomomi Yamada; Yuki Nishimura; Satoshi Tamaru; Naoko Asano; Kohta Miyawaki; Koji Izutsu; Tomohiro Kinoshita; Ritsuro Suzuki; Koichi Ohshima; Koji Kato; Naoyuki Katayama; Motoko Yamaguchi

  Cancer science, 16 Mar. 2023

  
• Risk factors for antibody-mediated rejection in ABO blood-type incompatible & donor-specific antibody-positive liver transplantation

  Tetsuya Tajima; Koichiro Hata; Hironori Haga; Jiro Kusakabe; Shoichi Kageyama; Kimiko Yurugi; Rie Hishida; Xiangdong Zhao; Momoko Nishikori; Miki Nagao; Akifumi Takaori-Kondo; Shinji Uemoto; Etsuro Hatano

  Liver Transplantation, 08 Feb. 2023

  
• Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T ‐cell therapy

  Naokazu Nakamura; Yasuyuki Arai; Toshio Kitawaki; Tomoyasu Jo; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori‐Kondo

  British Journal of Haematology, 11 Oct. 2022

  
• CD5+ DLBCLに対するDA-EPOCH-R/大量MTX療法 PEARL5試験の長期追跡結果(DA-EPOCH-R with high-dose methotrexate for CD5+ DLBCL: long-term follow-up results of PEARL5 study)

  宮崎 香奈; 酒井 リカ; 岩城 憲子; 山本 豪; 村山 佳予子; 錦織 桃子; 角南 一貴; 吉田 功; 矢野 寛樹; 山田 知美; 西村 有起; 田丸 智巳; 浅野 直子; 宮脇 恒太; 伊豆津 宏二; 木下 朝博; 鈴木 律朗; 大島 孝一; 加藤 光次; 片山 直之; 山口 素子

  日本血液学会学術集会, Sep. 2021

  
• Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.

  Makiko Yamasaki-Morita; Yasuyuki Arai; Takashi Ishihara; Tomoko Onishi; Hanako Shimo; Kayoko Nakanishi; Yukiko Nishiyama; Tomoyasu Jo; Hidefumi Hiramatsu; Takaya Mitsuyoshi; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Toshio Kitawaki; Keiji Nogami; Akifumi Takaori-Kondo; Miki Nagao; Souichi Adachi

  Blood advances, 26 Jul. 2022

  Access this paper :

  
• The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment.

  Hepei Yuan; Momoko Nishikori; Yasuyuki Otsuka; Hiroshi Arima; Toshio Kitawaki; Akifumi Takaori-Kondo

  Cancer science, Nov. 2021

  Access this paper :

  
• Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

  Nobuhiro Tsukada; Momoko Nishikori; Hiroaki Goto; Rie Kanamori; Satoshi Nishina; Takashi Seto; Shinsuke Iida

  Drugs - real world outcomes, Mar. 2022

  
• 肺腺がんを合併した小リンパ球性リンパ腫の3例

  天ヶ瀬 寛記; 錦織 桃子; 秋山 大介; 赤荻 杏奈; 島津 裕; 近藤 忠一; 山下 浩平; 高折 晃史

  臨床血液, Feb. 2022

  
• Immunohistochemistry of the oncofetal protein IMP3 is helpful in the diagnosis of intravascular large B‐cell lymphoma using skin biopsy

  Kentaro Odani; Masakazu Fujimoto; Masahiro Hirata; Momoko Nishikori; Shunya Usui; Yosuke Yamada; Miho Saeki; Kazuo Ono; Yoko Iwasa; Hironori Haga

  Journal of Cutaneous Pathology, 03 Jan. 2022

  
• A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein-Barr virus-positive diffuse large B-cell lymphoma.

  Hepei Yuan; Momoko Nishikori; Chiyoko Ueda; Masakazu Fujimoto; Takahiro Yasumi; Yasuyuki Otsuka; Toshio Kitawaki; Masahiro Hirata; Hironori Haga; Hirokazu Kanegane; Akifumi Takaori-Kondo

  Journal of clinical and experimental hematopathology : JCEH, 26 Oct. 2021

  
• PET-CT評価に注意を要した悪性リンパ腫症例

  井上 令一; 錦織 桃子; 近藤 忠一; 山下 浩平; 高折 晃史; 藤本 正数

  臨床血液, Sep. 2021

  
• サルコイドーシスの経過観察中に発症した肺門部の非ホジキンリンパ腫

  天ヶ瀬 寛記; 岩崎 惇; 進藤 岳郎; 諫田 淳也; 錦織 桃子; 近藤 忠一; 山下 浩平; 高折 晃史; 谷澤 公伸; 藤本 正数

  臨床血液, Sep. 2021

  
• Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.

  Koji Izutsu; Kiyoshi Ando; Momoko Nishikori; Hirohiko Shibayama; Takanori Teshima; Junya Kuroda; Koji Kato; Yoshitaka Imaizumi; Kisato Nosaka; Rika Sakai; Seiichiro Hojo; Tadashi Nakanishi; Shinya Rai

  Cancer science, Sep. 2021

  
• Post-transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1,954 Transplants.

  Tetsuya Tajima; Koichiro Hata; Hironori Haga; Momoko Nishikori; Katsutsugu Umeda; Jiro Kusakabe; Hidetaka Miyauchi; Tatsuya Okamoto; Eri Ogawa; Mari Sonoda; Hidefumi Hiramatsu; Masakazu Fujimoto; Hideaki Okajima; Junko Takita; Akifumi Takaori-Kondo; Shinji Uemoto

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 02 Mar. 2021

  Access this paper :

  
• Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development.

  Fumiya Moribe; Momoko Nishikori; Tsuyoshi Takashima; Daiki Taniyama; Nobuyuki Onishi; Hiroshi Arima; Hiroyuki Sasanuma; Remi Akagawa; Fathi Elloumi; Shunichi Takeda; Yves Pommier; Eiichi Morii; Akifumi Takaori-Kondo; Junko Murai

  PloS one, 2021

  
• Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group.

  Mizuki Watanabe; Junya Kanda; Yasuyuki Arai; Masakatsu Hishizawa; Momoko Nishikori; Takayuki Ishikawa; Kazunori Imada; Yasunori Ueda; Takashi Akasaka; Akihito Yonezawa; Masaharu Nohgawa; Toshiyuki Kitano; Mitsuru Itoh; Tomoharu Takeoka; Toshinori Moriguchi; Kazuhiro Yago; Nobuyoshi Arima; Naoyuki Anzai; Mitsumasa Watanabe; Tadakazu Kondo; Akifumi Takaori-Kondo

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Dec. 2020

  
• Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation

  Fumiya Wada; Momoko Nishikori; Masakatsu Hishizawa; Mitsumasa Watanabe; Akiko Aiba; Toshiyuki Kitano; Yayoi Shimazu; Takero Shindo; Tadakazu Kondo; Akifumi Takaori-Kondo

  International Journal of Hematology, Nov. 2020

  
• DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.

  Kana Miyazaki; Naoko Asano; Tomomi Yamada; Kohta Miyawaki; Rika Sakai; Tadahiko Igarashi; Momoko Nishikori; Kinya Ohata; Kazutaka Sunami; Isao Yoshida; Go Yamamoto; Naoki Takahashi; Masataka Okamoto; Hiroki Yano; Yuki Nishimura; Satoshi Tamaru; Masakatsu Nishikawa; Koji Izutsu; Tomohiro Kinoshita; Junji Suzumiya; Koichi Ohshima; Koji Kato; Naoyuki Katayama; Motoko Yamaguchi

  Haematologica, 01 Sep. 2020

  
• Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocation.

  Kiyotaka Izumi; Momoko Nishikori; Hepei Yuan; Yasuyuki Otsuka; Kensuke Nakao; Akifumi Takaori-Kondo

  Genes, chromosomes & cancer, Sep. 2020, Peer-reviewed

  
• Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.

  Takahiko Yasuda; Masashi Sanada; Dai Nishijima; Takashi Kanamori; Yuka Iijima; Hiroyoshi Hattori; Akiko Saito; Hiroaki Miyoshi; Yuichi Ishikawa; Norio Asou; Kensuke Usuki; Shinsuke Hirabayashi; Motohiro Kato; Masaki Ri; Hiroshi Handa; Tadao Ishida; Hirohiko Shibayama; Masahiro Abe; Chisako Iriyama; Kennosuke Karube; Momoko Nishikori; Koichi Ohshima; Keisuke Kataoka; Kenichi Yoshida; Yuichi Shiraishi; Hiroaki Goto; Souichi Adachi; Ryoji Kobayashi; Hitoshi Kiyoi; Yasushi Miyazaki; Seishi Ogawa; Hiroki Kurahashi; Hisayuki Yokoyama; Atsushi Manabe; Shinsuke Iida; Akihiro Tomita; Keizo Horibe

  Cancer science, 03 Jul. 2020, Peer-reviewed

  
• Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.

  Mizuki Watanabe; Junya Kanda; Masakatsu Hishizawa; Momoko Nishikori; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori-Kondo

  Annals of hematology, Jul. 2020, Peer-reviewed

  Access this paper :

  
• Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression.

  Naoki Tamura; Hirona Maeda; Momoko Nishikori; Haruyuki Fujita; Masakatsu Hishizawa; Hironori Haga; Akifumi Takaori-Kondo

  International journal of hematology, May 2020, Peer-reviewed

  
• LUBAC accelerates B-cell lymphomagenesis by conferring B cells resistance to genotoxic stress.

  Tomoyasu Jo; Momoko Nishikori; Yasunori Kogure; Hiroshi Arima; Katsuhiro Sasaki; Yoshiteru Sasaki; Tomoko Nakagawa; Fumie Iwai; Shuji Momose; Aki Shiraishi; Hiroshi Kiyonari; Noritaka Kagaya; Tetsuo Onuki; Kazuo Shin-Ya; Minoru Yoshida; Keisuke Kataoka; Seishi Ogawa; Kazuhiro Iwai; Akifumi Takaori-Kondo

  Blood, 23 Apr. 2020, Peer-reviewed

  
• Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab.

  Fumiya Wada; Tadakazu Kondo; Momoko Nakamura; Kazuhisa Chonabayashi; Momoko Nishikori; Masakatsu Hishizawa; Kouhei Yamashita; Akifumi Takaori-Kondo

  Annals of hematology, Apr. 2020, Peer-reviewed

  Access this paper :

  
• EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.

  Yasuyuki Otsuka; Momoko Nishikori; Hiroshi Arima; Kiyotaka Izumi; Toshio Kitawaki; Masakatsu Hishizawa; Akifumi Takaori-Kondo

  Molecular immunology, Mar. 2020, Peer-reviewed

  
• SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma.

  Akihiko Sugimoto; Tatsuki R Kataoka; Hiroaki Ito; Kyohei Kitamura; Narumi Saito; Masahiro Hirata; Chiyuki Ueshima; Yusuke Takei; Koki Moriyoshi; Yasuyuki Otsuka; Momoko Nishikori; Akifumi Takaori-Kondo; Hironori Haga

  Scientific reports, 13 Feb. 2020, Peer-reviewed

  Access this paper :

  
• Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.

  Kiyotaka Izumi; Junya Kanda; Momoko Nishikori; Yasuyuki Arai; Takayuki Ishikawa; Satoshi Yoshioka; Yasunori Ueda; Takeshi Maeda; Akihito Yonezawa; Naoyuki Anzai; Toshinori Moriguchi; Kazunori Imada; Takashi Akasaka; Masaharu Nohgawa; Mitsuru Itoh; Akiko Aiba; Hiroko Tsunemine; Mitsumasa Watanabe; Tadakazu Kondo; Akifumi Takaori-Kondo

  Annals of hematology, Dec. 2019, Peer-reviewed

  
• DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 study.

  Kana Miyazaki; Naoko Asano; Tomomi Yamada; Kohta Miyawaki; Rika Sakai; Tadahiko Igarashi; Momoko Nishikori; Kinya Ohata; Kazutaka Sunami; Isao Yoshida; Go Yamamoto; Naoki Takahashi; Masataka Okamoto; Hiroki Yano; Yuki Nishimura; Satoshi Tamaru; Masakatsu Nishikawa; Koji Izutsu; Tomohiro Kinoshita; Junji Suzumiya; Koichi Ohshima; Koji Kato; Naoyuki Katayama; Motoko Yamaguchi

  Haematologica, 24 Oct. 2019, Peer-reviewed

  
• Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma.

  Eisei Kondo; Takashi Ikeda; Hiroaki Goto; Momoko Nishikori; Naoko Maeda; Kimikazu Matsumoto; Hideo Kitagawa; Naoto Noda; Saori Sugimoto; Junichi Hara

  Cancer chemotherapy and pharmacology, Oct. 2019, Peer-reviewed

  
• Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?

  Tetsuya Tajima; Koichiro Hata; Hideaki Okajima; Momoko Nishikori; Kentaro Yasuchika; Jiro Kusakabe; Atsushi Yoshizawa; Ken Fukumitsu; Takayuki Anazawa; Hirokazu Tanaka; Seidai Wada; Junshi Doi; Akifumi Takaori-Kondo; Shinji Uemoto

  Transplantation direct, Oct. 2019, Peer-reviewed

  
• Effectiveness of cord blood transplantation for the treatment of refractory angioimmunoblastic T-cell lymphoma: a series of three cases.

  Yasuhiro Kazuma; Yayoi Shimazu; Masakatsu Hishizawa; Momoko Nishikori; Toshiyuki Kitano; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori-Kondo

  Bone marrow transplantation, Oct. 2019, Peer-reviewed

  
• [Ⅲ.Diagnosis and Treatment of Hodgkin Lymphoma].

  Momoko Nishikori

  Gan to kagaku ryoho. Cancer & chemotherapy, May 2019, Peer-reviewed

  
• Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.

  Yoshinobu Konishi; Tadakazu Kondo; Kensuke Nakao; Kohusuke Asagoe; Yasuyuki Otsuka; Momoko Nishikori; Masakatsu Hishizawa; Kouhei Yamashita; Akifumi Takaori-Kondo

  Bone marrow transplantation, Feb. 2019, Peer-reviewed

  
• [The immune microenvironment in malignant lymphoma].

  Momoko Nishikori

  [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Peer-reviewed

  
• Recurrent Epstein-Barr Virus-positive (EBV+) Primary Central Nervous System Lymphoma (PCNSL) in a Patient with Clinical Features of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

  Masahiro Nagano; Takashi Ayaki; Natsuko Koita; Toshiyuki Kitano; Momoko Nishikori; Naoki Goda; Sachiko Minamiguchi; Akio Ikeda; Akifumi Takaori-Kondo; Ryosuke Takahashi

  Internal medicine (Tokyo, Japan), 2019, Peer-reviewed

  Access this paper :

  
• [Hodgkin lymphoma].

  Momoko Nishikori

  [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Peer-reviewed

  
• 日本人再発難治性MCL患者に対するIbrutinibの第II相試験：最終解析結果

  福原規子; 永井宏和; 丸山 大; 北野俊行; 石川隆之; 柴山浩彦; 崔 日承; 畠 清彦; 内田俊樹; 錦織桃子; 木下朝博; 松野吉宏; 西川智章; 飛内賢正

  第80回日本血液学会学術集会, Oct. 2018, Peer-reviewed

  
• B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.

  Hiroshi Arima; Momoko Nishikori; Yasuyuki Otsuka; Wataru Kishimoto; Kiyotaka Izumi; Koubun Yasuda; Tomohiro Yoshimoto; Akifumi Takaori-Kondo

  Blood advances, 25 Sep. 2018, Peer-reviewed

  
• Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma.

  Hiroshi Arima; Masakazu Fujimoto; Momoko Nishikori; Toshiyuki Kitano; Wataru Kishimoto; Masakatsu Hishizawa; Tadakazu Kondo; Kouhei Yamashita; Masahiro Hirata; Hironori Haga; Akifumi Takaori-Kondo

  Leukemia & lymphoma, Sep. 2018, Peer-reviewed

  
• Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.

  Otsuka Y; Nishikori M; Kitano T; Oka T; Ishikawa T; Haga H; Takaori-Kondo A

  Clinical case reports, Apr. 2017, Peer-reviewed

  Access this paper :

  
• Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis

  Hiroyuki Yamazaki; Kazunari Aoki; Tadakazu Kondo; Momoko Nishikori; Toshiyuki Kitano; Masakatsu Hishizawa; Kouhei Yamashita; Akifumi Takaori-Kondo

  ANNALS OF HEMATOLOGY, Feb. 2017, Peer-reviewed

  
• PD-1 blockade therapy in lymphoid malignancies.

  Nishikori M; Takaori-Kondo A

  [Rinsho ketsueki] The Japanese journal of clinical hematology, 2017, Peer-reviewed

  
• Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+DLBCL): Interim Results from a Phase II Study

  Miyazaki Kana; Asano Naoko; Yamada Tomomi; Takasaki Hirotaka; Igarashi Tadahiko; Nishikori Momoko; Ohata Kinya; Sunami Kazutaka; Yoshida Isao; Niitsu Nozomi; Okamoto Masataka; Yano Hiroki; Nishimura Yuki; Tamaru Satoshi; Izutsu Koji; Kinoshita Tomohiro; Suzumiya Junji; Nishikawa Masakatsu; Katayama Naoyuki; Yamaguchi Motoko

  BLOOD, 02 Dec. 2016, Peer-reviewed

  
• Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

  Dai Maruyama; Hirokazu Nagai; Noriko Fukuhara; Toshiyuki Kitano; Takayuki Ishikawa; Hirohiko Shibayama; Ilseung Choi; Kiyohiko Hatake; Toshiki Uchida; Momoko Nishikori; Tomohiro Kinoshita; Yoshihiro Matsuno; Tomoaki Nishikawa; Satoko Takahara; Kensei Tobinai

  CANCER SCIENCE, Dec. 2016, Peer-reviewed

  Access this paper :

  
• Expression of Tim-1 in primary CNS lymphoma

  Wataru Kishimoto; Momoko Nishikori; Hiroshi Arima; Hiroaki Miyoshi; Yuya Sasaki; Toshio Kitawaki; Kotaro Shirakawa; Takeharu Kato; Yoshitaka Imaizumi; Takayuki Ishikawa; Hitoshi Ohno; Hironori Haga; Koichi Ohshima; Akifumi Takaori-Kondo

  CANCER MEDICINE, Nov. 2016, Peer-reviewed

  Access this paper :

  
• A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.

  Umeda M; Kondo T; Nishikori M; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A

  Clinical case reports, Jan. 2016, Peer-reviewed

  Access this paper :

  
• STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas

  Noriaki Yoshida; Shinobu Tsuzuki; Kennosuke Karube; Taishi Takahara; Miyuki Suguro; Hiroaki Miyoshi; Momoko Nishikori; Masanori Shimoyama; Kunihiro Tsukasaki; Koichi Ohshima; Masao Seto

  CANCER SCIENCE, Oct. 2015, Peer-reviewed

  Access this paper :

  
• Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan

  Dai Chihara; Naoko Asano; Ken Ohmachi; Tomohiro Kinoshita; Masataka Okamoto; Yoshinobu Maeda; Ishikazu Mizuno; Kosei Matsue; Toshiki Uchida; Hirokazu Nagai; Momoko Nishikori; Shigeo Nakamura; Michinori Ogura; Ritsuro Suzuki

  BRITISH JOURNAL OF HAEMATOLOGY, Sep. 2015, Peer-reviewed

  
• Increased number of peripheral CD8(+) T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine

  Momoko Nishikori; Toshiyuki Kitano; Masayuki Kobayashi; Masakatsu Hishizawa; Toshio Kitawaki; Tadakazu Kondo; Kouhei Yamashita; Hiroshi Kawabata; Norimitsu Kadowaki; Yusuke Takei; Hironori Haga; Akifumi Takaori-Kondo

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jul. 2015, Peer-reviewed

  Access this paper :

  
• Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

  Dai Chihara; N. Asano; K. Ohmachi; M. Nishikori; M. Okamoto; M. Sawa; R. Sakai; Y. Okoshi; N. Tsukamoto; Y. Yakushijin; S. Nakamura; T. Kinoshita; M. Ogura; R. Suzuki

  Annals of Oncology, 01 May 2015, Peer-reviewed

  
• Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

  D. Chihara; N. Asano; K. Ohmachi; M. Nishikori; M. Okamoto; M. Sawa; R. Sakai; Y. Okoshi; N. Tsukamoto; Y. Yakushijin; S. Nakamura; T. Kinoshita; M. Ogura; R. Suzuki

  ANNALS OF ONCOLOGY, May 2015, Peer-reviewed

  
• Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma

  Yasuyuki Arai; Kouhei Yamashita; Kiyomi Mizugishi; Momoko Nishikori; Masakatsu Hishizawa; Tadakazu Kondo; Toshiyuki Kitano; Hiroshi Kawabata; Norimitsu Kadowaki; Akifumi Takaori-Kondo

  Hematology, May 2015, Peer-reviewed

  
• Plasmacytic ALK-positive large B-cell lymphoma: A potential mimic of extramedullary plasmacytoma

  Taiki Hashimoto; Masakazu Fujimoto; Momoko Nishikori; Kengo Takeuchi; Mizuki Kimura; Naoki Nakajima; Aya Miyagawa-Hayashino; Akifumi Takaori-Kondo; Hironori Haga

  PATHOLOGY INTERNATIONAL, Jun. 2014, Peer-reviewed

  
• Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma

  Shogo Kumagai; Masaharu Tashima; Jun Fujikawa; Makoto Iwasaki; Yoshihiro Iwamoto; Yuki Sueki; Akiko Fukunaga; Soshi Yanagita; Momoko Nishikori; Akifumi Takaori-Kondo; Nobuyoshi Arima

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jun. 2014, Peer-reviewed

  
• A Clinical, Pathological, and Genetic Characterization of Methotrexate-associated Lymphoproliferative Disorders

  Noriyuki Yamakawa; Masakazu Fujimoto; Daisuke Kawabata; Chikashi Terao; Momoko Nishikori; Ran Nakashima; Yoshitaka Imura; Naoichiro Yukawa; Hajime Yoshifuji; Koichiro Ohmura; Takao Fujii; Toshiyuki Kitano; Tadakazu Kondo; Kimiko Yurugi; Yasuo Miura; Taira Maekawa; Hiroh Saji; Akifumi Takaori-Kondo; Fumihiko Matsuda; Hironori Haga; Tsuneyo Mimori

  JOURNAL OF RHEUMATOLOGY, Feb. 2014, Peer-reviewed

  
• Molecular Pathogenesis of Follicular Lymphoma

  Kishimoto W; Nishikori M

  Journal of Clinical and Experimental Hematopathology, 2014, Peer-reviewed

  
• [The role of chromosomal translocations in the pathogenesis of B-cell lymphomas].

  M. Nishikori

  [Rinshō ketsueki] The Japanese journal of clinical hematology, Oct. 2013, Peer-reviewed

  
• Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis

  Noriaki Yoshida; Momoko Nishikori; Tohru Izumi; Yoshitaka Imaizumi; Yasushi Sawayama; Daisuke Niino; Masaharu Tashima; Sayuri Hoshi; Koichi Ohshima; Masanori Shimoyama; Masao Seto; Kunihiro Tsukasaki

  BRITISH JOURNAL OF HAEMATOLOGY, Apr. 2013, Peer-reviewed

  
• Long-term remission in patients with plasma cell myeloma after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation::A 10-year single-center experience

  Mori Minako; Kondo Tadakazu; Hishizawa Masakatsu; Nishikori Momoko; Yamashita Kouhei; Ichinohe Tatsuo; Kadowaki Norimitsu; Ishikawa Takayuki; Takaori-Kondo Akifumi

  Journal of Hematopoietic Cell Transplantation, 2013

  
• Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.

  Hiroshi Kawabata; Norimitsu Kadowaki; Momoko Nishikori; Toshio Kitawaki; Tadakazu Kondo; Takayuki Ishikawa; Hajime Yoshifuji; Noriyuki Yamakawa; Yoshitaka Imura; Tsuneyo Mimori; Yumi Matsumura; Yoshiki Miyachi; Takeshi Matsubara; Motoko Yanagita; Hironori Haga; Akifumi Takaori-Kondo

  Journal of clinical and experimental hematopathology : JCEH, 2013, Peer-reviewed

  
• [Pathogenesis and treatment of follicular lymphoma].

  M. Nishikori

  Nihon rinsho. Japanese journal of clinical medicine, Apr. 2012, Peer-reviewed

  
• A case of ureteral malignant lymphoma with concentric thickening of the ureteral wall

  Takao Haitani; Yosuke Shimizu; Takahiro Inoue; Kazutoshi Okubo; Jun Watanabe; Tomomi Kamba; Koji Yoshimura; Akihiro Kanematsu; Hiroyuki Nishiyama; Osamu Ogawa; Shinji Sumiyoshi; Yoshiki Mikami; Momoko Nishikori

  Acta Urologica Japonica, Apr. 2012, Peer-reviewed

  Access this paper :

  
• 濾胞性リンパ腫の治療に伴い小脳失調症状が改善した傍腫瘍性症候群の一症例

  松山 裕文; 皆川 栄子; 猪原 匡史; 端 祐一郎; 高橋 良輔; 吉田 園代; 島津 弥生; 錦織 桃子; 菱澤 方勝; 近藤 忠一; 石川 隆之; 高折 晃史; 北野 俊行

  臨床神経学, Feb. 2012

  
• Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment

  M. Ishihara; C. Nishida; Y. Tashiro; I. Gritli; J. Rosenkvist; M. Koizumi; Y. Okaji; R. Yamamoto; H. Yagita; K. Okumura; M. Nishikori; K. Wanaka; Y. Tsuda; Y. Okada; H. Nakauchi; B. Heissig; K. Hattori

  LEUKEMIA, Feb. 2012, Peer-reviewed

  
• A Case of Follicular Lymphoma Associated with Paraneoplastic Cerebellar Degeneration

  Yayoi Shimazu; Eiko N. Minakawa; Momoko Nishikori; Masafumi Ihara; Yuichiro Hashi; Hirofumi Matsuyama; Masakatsu Hishizawa; Sonoyo Yoshida; Toshiyuki Kitano; Tadakazu Kondo; Takayuki Ishikawa; Ryosuke Takahashi; Akifumi Takaori-Kondo

  INTERNAL MEDICINE, 2012, Peer-reviewed

  
• CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab

  K. Miyazaki; M. Yamaguchi; R. Suzuki; Y. Kobayashi; A. M. Maeshima; N. Niitsu; D. Ennishi; J. -I. Tamaru; K. Ishizawa; M. Kashimura; Y. Kagami; K. Sunami; H. Yamane; M. Nishikori; H. Kosugi; T. Yujiri; R. Hyo; N. Katayama; T. Kinoshita; S. Nakamura

  ANNALS OF ONCOLOGY, Jul. 2011, Peer-reviewed

  
• [Current topics on the pathophysiology of follicular lymphoma].

  M. Nishikori

  [Rinshō ketsueki] The Japanese journal of clinical hematology, Oct. 2010, Peer-reviewed

  
• A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy

  Haruyuki Fujita; Momoko Nishikori; Akifumi Takaori-Kondo; Noriyoshi Yoshinaga; Yoshiaki Ohara; Takayuki Ishikawa; Hironori Haga; Takashi Uchiyama

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2010, Peer-reviewed

  
• Scleredema with diffuse pigmentation

  H. Minato; M. Nishikori; M. Tanioka; Y. Miyachi; A. Utani

  JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, Jan. 2010, Peer-reviewed

  
• Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type

  Tomomi Sakai; Momoko Nishikori; Masaharu Tashima; Ryo Yamamoto; Toshio Kitawaki; Akifumi Takaori-Kondo; Takayo Suzuki; Shinobu Tsuzuki; Takashi Uchiyama

  CANCER SCIENCE, Dec. 2009, Peer-reviewed

  
• B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma

  Ryo Yamamoto; Momoko Nishikori; Masaharu Tashima; Tomomi Sakai; Tatsuo Ichinohe; Akifumi Takaori-Kondo; Katsuyuki Ohmori; Takashi Uchiyama

  CANCER SCIENCE, Nov. 2009, Peer-reviewed

  
• Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma

  M. Nishikori

  [Rinshō ketsueki] The Japanese journal of clinical hematology, Oct. 2009, Peer-reviewed

  
• Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation

  Hitoshi Ohno; Momoko Nishikori; Hironori Haga; Kotaro Isoda

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jun. 2009, Peer-reviewed

  
• Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning

  Chisaki Mizumoto; Junya Kanda; Tatsuo Ichinohe; Takayuki Ishikawa; Masashi Matsui; Norimitsu Kadowaki; Tadakazu Kondo; Kazunori Imada; Masakatsu Hishizawa; Hiroshi Kawabata; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori-Kondo; Toshiyuki Hori; Takashi Uchiyama

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2009, Peer-reviewed

  
• De novo CD5(+) diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients

  Motoko Yamaguchi; Naoya Nakamura; Ritsuro Suzuki; Yoshitoyo Kagami; Masataka Okamoto; Ryo Ichinohasama; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Koichi Ohshima; Momoko Nishikori; Jun-ichi Tamaru; Masafumi Taniwaki; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura

  HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Aug. 2008, Peer-reviewed

  
• PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

  Ryo Yamamoto; Momoko Nishikori; Toshio Kitawaki; Tomomi Sakai; Masakatsu Hishizawa; Masaharu Tashima; Tadakazu Kondo; Katsuyuki Ohmori; Masayuki Kurata; Takamasa Hayashi; Takashi Uchiyama

  BLOOD, Mar. 2008, Peer-reviewed

  
• Requirement of non-canonical activity of uracil DNA glycosylase for class switch recombination

  Nasim A. Begum; Nakako Izumi; Momoko Nishikori; Hitoshi Nagaoka; Reiko Shinkura; Tasuku Honjo

  JOURNAL OF BIOLOGICAL CHEMISTRY, Jan. 2007, Peer-reviewed

  
• Molecular pathogenesis of Hodgkin lymphoma

  M Nishikori; T Uchiyama

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jun. 2006, Peer-reviewed

  
• Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia

  M Hishizawa; K Imada; T Sakai; M Nishikori; N Arima; M Tsudo; T Ishikawa; T Uchiyama

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2006, Peer-reviewed

  
• Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma

  H Ohno; M Nishikori; Y Maesako; H Haga

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Dec. 2005, Peer-reviewed

  
• Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappa B p52, which is associated with hyperphosphorylated Bcl-3

  M Nishikori; H Ohno; H Haga; T Uchiyama

  CANCER SCIENCE, Aug. 2005, Peer-reviewed

  
• Classical and alternative NF-kB activation pathways and their roles in lymphoid malignancies

  Nishikori M

  Journal of Clinical and Experimental Hematopathology, 2005, Peer-reviewed

  
• Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma

  C Ueda; M Nishikori; T Kitawaki; T Uchiyama; H Ohno

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jan. 2004, Peer-reviewed

  
• High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

  M Nishikori; Y Maesako; C Ueda; M Kurata; T Uchiyama; H Ohno

  BLOOD, Apr. 2003, Peer-reviewed

  
• Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6

  M Kurata; Y Maesako; C Ueda; M Nishikori; T Akasaka; T Uchiyama; H Ohno

  CANCER RESEARCH, Nov. 2002, Peer-reviewed

  
• The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma

  C Ueda; T Akasaka; M Kurata; Y Maesako; M Nishikori; R Ichinohasama; K Imada; T Uchiyama; H Ohno

  ONCOGENE, Jan. 2002, Peer-reviewed

  
• Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5 ' region of BCL2 in B-cell tumors

  N Yonetani; C Ueda; T Akasaka; M Nishikori; T Uchiyama; H Ohno

  JAPANESE JOURNAL OF CANCER RESEARCH, Sep. 2001, Peer-reviewed

  
• Primary mediastinal large B-cell lymphoma: A comparative study with nodular sclerosis-type Hodgkin's disease

  N Yonetani; M Kurata; M Nishikori; H Haga; K Ohmori; H Yamabe; T Uchiyama; H Ohno

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Aug. 2001, Peer-reviewed

  

Misc.

• Investigation of risk factors contributing to reduced exercise tolerance after CAR-T cell therapy

  濱田涼太; 新井康之; 新井康之; 北脇年雄; 村尾昌信; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 福田裕子; 錦織桃子; 諫田淳也; 水本智咲; 池口良輔; 松田秀一; 高折晃史; 高折晃史

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• CAR-T細胞療法後の再発に臍帯血移植で寛解が維持されたびまん性大細胞型B細胞リンパ腫の一例

  菱澤方勝; 植田知代子; 岸本渉; 島津弥生; 濱田常義; 中村直和; 鈴木光太郎; 島津裕; 錦織桃子; 高折晃史; 森口寿徳

  日本輸血細胞治療学会誌, 2024

  
• 血液型不適合/既存ドナー特異的抗体陽性肝移植における抗体関連拒絶反応の発症危険因子は何か?

  田嶋哲也; 田嶋哲也; 秦浩一郎; 秦浩一郎; 日下部治郎; 日下部治郎; 宮内英孝; 宮内英孝; 万木紀美子; 菱田理恵; 影山詔一; 影山詔一; 錦織桃子; 長尾美紀; 高折晃史; 羽賀博典; 上本伸二; 上本伸二; 波多野悦朗; 波多野悦朗

  日本移植学会総会プログラム抄録集, 2021

  
• PD-1/PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

  山本 玲; 錦織 桃子

  血液・腫瘍科, Aug. 2008

  
• 肝移植後リンパ増殖性疾患(PTLD)の頻度,治療とその予後~当院1,954例の後方視的解析から~

  田嶋哲也; 秦浩一郎; 羽賀博典; 錦織桃子; 日下部治郎; 宮内英孝; 岡本竜弥; 小川絵里; 園田真理; 岡島英明; 高折晃史; 上本伸二

  日本外科学会定期学術集会(Web), 2021

  
• The current situation and problem of treatment for primary central nervous system lymphoma in elders

  牧野恭秀; 荒川芳輝; 丹治正大; 峰晴陽平; 錦織桃子; 高折晃史; 宇藤恵; 溝脇尚志; 宮本享

  日本脳腫瘍学会プログラム・抄録集, 2020

  
• 血液型不適合肝臓移植の現状と課題 Rituximabによる術前減感作療法時代の血液型不適合成人生体肝移植の治療成績 抗体関連拒絶反応発症の危険因子は何か?

  田嶋 哲也; 秦 浩一郎; 日下部 治郎; 宮内 英孝; 穴澤 貴之; 錦織 桃子; 海道 利実; 羽賀 博典; 高折 晃史; 上本 伸二

  移植, Sep. 2019

  
• CD5+ DLBCLに対するDA-EPOCH-R/大量MTX療法 PEARL5試験の主解析結果(DA-EPOCH-R with high-dose methotrexate(HD-MTX) for CD5+ DLBCL: Primary analysis of PEARL5 study)

  宮崎 香奈; 浅野 直子; 山田 知美; 宮脇 恒太; 高崎 啓孝; 五十嵐 忠彦; 錦織 桃子; 大畑 欣也; 角南 一貴; 吉田 功; 山本 豪; 高橋 直樹; 岡本 昌隆; 矢野 寛樹; 西村 有起; 田丸 智巳; 西川 政勝; 伊豆津 宏二; 木下 朝博; 鈴宮 淳司; 大島 孝一; 加藤 光次; 片山 直之; 山口 素子

  臨床血液, Sep. 2018

  
• 日本人再発難治性MCL患者に対するIbrutinibの第II相試験 最終解析結果(Phase 2 study of ibrutinib in Japanese patients with relapsed/refractory MCL: final analysis)

  福原 規子; 永井 宏和; 丸山 大; 北野 俊行; 石川 隆之; 柴山 浩彦; 崔 日承; 畠 清彦; 内田 俊樹; 錦織 桃子; 木下 朝博; 松野 吉宏; 西川 智章; 飛内 賢正

  臨床血液, Sep. 2018

  
• 生体肝移植後リンパ増殖性疾患(PTLD)の頻度・治療とその予後:当院1875例の後方視的解析から

  田嶋哲也; 秦浩一郎; 錦織桃子; 伊藤孝司; 穴澤貴行; 福光剣; 八木真太郎; 岡島英明; 海道利実; 羽賀博典; 高折晃史; 上本伸二

  日本移植学会総会プログラム抄録集, Sep. 2018

  
• 血液疾患,診断と治療のtrends&topics ホジキンリンパ腫

  錦織桃子

  Mebio, 10 Jun. 2017

  
• リンパ腫診療における免疫チェックポイント阻害剤の役割

  錦織桃子; 高折晃史

  日本リンパ網内系学会会誌, 30 May 2017

  
• 極めて長期の寛解期間後に再発した悪性リンパ腫の2症例

  大塚泰幸; 錦織桃子; 岡知美; 北野俊行; 高折晃史

  日本リンパ網内系学会会誌, 30 May 2017

  
• 中枢神経系原発悪性リンパ腫に対するmodified Bonn protocolの治療成績

  牧野恭秀; 荒川芳輝; 丹治正大; 峰晴陽平; 北野俊行; 錦織桃子; 高木康志; 高折晃史; 宮本享

  日本脳腫瘍学会プログラム・抄録集, 2017

  
• Notch1-Activated B Cells Have an Immunomodulatory Function Enhancing Th2 and Treg Immune Response Via IL-33-ST2 Pathway

  Hiroshi Arima; Momoko Nishikori; Yasuyuki Otsuka; Kiyotaka Izumi; Wataru Kishimoto; Akifumi Takaori-Kondo

  BLOOD, Dec. 2016

  
• 極めて急速な臨床経過をたどったcMYC/IGH,BCL2/IGH,PAX5/IGH転座を有するtriple‐hit lymphomaの一例

  大塚泰幸; 白川康太郎; 錦織桃子; 菱澤方勝; 北野俊行; 羽賀博典; 高折晃史

  日本リンパ網内系学会会誌, 05 Aug. 2016

  
• ホジキンリンパ腫 5.ホジキンリンパ腫の免疫微小環境

  錦織桃子

  血液フロンティア, 30 Jan. 2016

  
• 自家移植後に早期再発したホジキンリンパ腫にブレンツキシマブ・ベドチンが奏効し同種移植を施行した1例

  藤田真梨; 末木佑季; 錦織桃子; 近藤忠一; 北野俊行; 菱澤方勝; 高折晃史

  臨床血液, 30 Nov. 2015

  
• 外来で診るリンパ腫・骨髄腫 リンパ系腫瘍に関する治療開発のトピックス リンパ腫に対する免疫チェックポイントを標的とした抗体療法

  錦織桃子

  Medicina, 10 Nov. 2015

  
• リンパ組織の生物学とリンパ腫の発症機序 リンパ腫発症の分子生物学的機序 B細胞リンパ腫

  錦織桃子

  日本臨床, 20 Oct. 2015

  
• 私のこの一枚(135)ホジキンリンパ腫におけるPD‐1シグナリング

  錦織桃子

  血液フロンティア, 30 Aug. 2015

  
• 悪性リンパ腫における免疫チェックポイント阻害剤の基礎と臨床

  錦織桃子; 高折晃史

  日本リンパ網内系学会会誌, 18 Jun. 2015

  
• 後天性血友病XIII(13)が疑われた,播種性血管内凝固症候群を併発した慢性骨髄単球性白血病の一例

  大塚泰幸; 惣宇利正善; 尾崎司; 一瀬白帝; 錦織桃子; 高折晃史

  日本血栓止血学会誌, 01 Apr. 2015

  
• 中枢神経系悪性リンパ腫に対するMTX+Ara‐C(modified Bonn protocol)の治療成績

  牧野恭秀; 荒川芳輝; 福井伸行; 丹治正大; 峰晴陽平; 北野俊行; 錦織桃子; 高木康志; 高折晃史; 宮本享

  日本脳腫瘍学会プログラム・抄録集, 2015

  
• ゲノム解析が明らかにした新しい血液疾患の病態と分類 ゲノム解析によるB細胞リンパ腫の病態理解の進歩

  錦織桃子

  月刊血液内科, 28 Dec. 2014

  
• Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

  Dai Chihara; Naoko Asano; Ohmachi Ken; Momoko Nishikori; Masataka Okamoto; Masashi Sawa; Rika Sakai; Yasushi Okoshi; Norifumi Tsukamoto; Yoshihiro Yakushijin; Shigeo Nakamura; Tomohiro Kinoshita; Michinori Ogura; Ritsuro Suzuki

  BLOOD, Dec. 2014

  
• Expression of Tim-1 and Its Pathogenetic Role in Primary CNS Lymphoma

  Momoko Nishikori; Wataru Kishimoto; Hiroshi Arima; Kotaro Shirakawa; Toshio Kitawaki; Akifumi Takaori-Kondo

  BLOOD, Dec. 2014

  
• STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

  Noriaki Yoshida; Shinobu Tsuzuki; Kennosuke Karube; Miyuki Katayama; Taishi Takahara; Shigeo Nakamura; Momoko Nishikori; Masanori Shimoyama; Koichi Ohshima; Kunihiro Tsukasaki; Masao Seto

  BLOOD, Dec. 2014

  
• CIDP類似の脱髄性ニューロパチーが先行した悪性リンパ腫による傍腫瘍性症候群の1例

  MAEDA KAZUHIKO; GOTO KAZUYA; MATSUMOTO RIKI; YAMAZAKI HIROAKI; NISHIKORI MOMOKO; KITANO TOSHIYUKI; SAWAMOTO NOBUKATSU; TAKAORI AKIFUMI; TAKAHASHI RYOSUKE

  日本神経学会学術大会プログラム・抄録集, Dec. 2014

  
• B細胞性リンパ腫の臨床像と分子病態

  錦織桃子

  日本リンパ網内系学会会誌, 06 Jun. 2014

  
• STX11はT細胞性腫瘍特異的ながん抑制遺伝子である

  YOSHIDA CHIAKI; TSUZUKI SHINOBU; KARUBE KENNOSUKE; TAKAHARA TAISHI; TAKAHARA TAISHI; NISHIKORI MOMOKO; SHIMOYAMA MASANORI; OSHIMA KOICHI; TSUKASAKI KUNIHIRO; SETO MASAO

  日本リンパ網内系学会会誌, 06 Jun. 2014

  
• 血液疾患とクローン性 3.造血器腫瘍のクローン性進展 2)低悪性度リンパ腫の形質転換とクローン性進展

  錦織桃子

  血液フロンティア, 30 May 2014

  
• 骨髄移植症例におけるドナー由来HLA抗体への対応

  YURUGI KIMIKO; MIURA YASUO; HISHIDA RIE; HIRAI HIDEYO; KITAWAKI TOSHIO; NISHIKORI MOMOKO; HISHIZAWA MASAKATSU; KONDO TADAKAZU; KITANO TOSHIYUKI; TAKAORI AKIFUMI; MAEKAWA TAIRA

  日本輸血細胞治療学会誌, 10 Apr. 2014

  
• 骨髄移植症例におけるドナー由来HLA抗体への対応

  YURUGI KIMIKO; MIURA YASUO; HISHIDA RIE; HIRAI HIDEYO; MAEKAWA TAIRA; KITAWAKI TOSHIO; NISHIKORI MOMOKO; HISHIZAWA KATAKATSU; KONDO TADAKAZU; KITANO TOSHIYUKI; TAKAORI AKIFUMI; ASHIHARA HIDEJI

  臨床血液, 28 Feb. 2014

  
• 当科におけるNK/T細胞性リンパ腫に対する造血幹細胞移植の治療成績

  YAMAZAKI HIROAKI; KONDO TADAKAZU; NISHIKIORI MOMOKO; KITANO TOSHIYUKI; TAKAORI AKIFUMI

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 中枢神経浸潤をきたした造血器悪性腫瘍に対して当院にて造血幹細胞移植を施行した9症例の治療成績

  YAMAMOTO KAZUYO; KONDO TADAKAZU; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; HISHIZAWA MASAKATSU; KITANO TOSHIYUKI; KAWABATA HIROSHI; KADOWAKI NORIMITSU; TAKAORI AKIFUMI

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 再発・治療抵抗性ホジキンリンパ腫に対する自家移植と同種移植の成績の比較

  YAMAMOTO RYUSUKE; KONDO TADAKAZU; NISHIKORI MOMOKO; KITANO TOSHIYUKI; TAKAORI AKIFUMI

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• Recommendation for the optimal use of bendamustine in Japan

  大間知謙; 丸山大; 錦織桃子; 鈴木達也; 伊豆津宏二

  臨床血液, 2014

  
• 多発性硬化症治療中に発症した中枢神経系原発悪性リンパ腫

  NAGAI YASUNORI; ARAKAWA YOSHITERU; NISHIKORI MOMOKO; KITANO TOSHIYUKI; NISHIDA NAMIKO; KUNIEDA TAKEHARU; TAKAGI YASUSHI; IWASAKI KOICHI; TAKAORI AKIFUMI; MIYAMOTO SUSUMU

  日本脳腫瘍学会プログラム・抄録集, 2014

  
• 頭蓋内原発のlymphoplasmacytic lymphomaと考えられた1例

  MAKINO YASUHIDE; ARAKAWA YOSHITERU; KITANO TOSHIYUKI; NISHIKORI MOMOKO; TAKAGI YASUSHI; TAKAORI AKIFUMI; MIYAMOTO SUSUMU

  日本脳腫瘍学会プログラム・抄録集, 2014

  
• リンパ系腫瘍―最新の病態解析と治療―濾胞性リンパ腫の分子病態

  岸本渉; 錦織桃子

  最新医学, 10 Oct. 2013

  
• 薬剤性心腎機能障害とCMV網膜炎を伴った難治性濾胞性リンパ腫に対し臍帯血ミニ移植を実施し寛解を維持している1例

  KAWADA TAKEHITO; NISHIKORI MOMOKO; SHIMURA KAZUHO; KITANO TOSHIYUKI; KONDO TADAKAZU; KADOWAKI NORIMITSU; TAKAORI AKIFUMI

  日本リンパ網内系学会会誌, 19 Apr. 2013

  
• The role of chromosomal translocations in the pathogenesis of B-cell lymphomas

  錦織桃子

  臨床血液, 2013

  
• 中枢神経系悪性リンパ腫に対するMTX+Ara‐Cによる化学療法単独治療

  MAKINO YASUHIDE; ARAKAWA YOSHITERU; KITANO TOSHIYUKI; NISHIKORI MOMOKO; TAKAGI YASUSHI; TAKAHASHI JUN; TAKAORI AKIFUMI; MIYAMOTO SUSUMU

  日本脳腫瘍学会プログラム・抄録集, 2013

  
• Deregulation of CCND1 or BCL2 in the Immature B-Cell Stage Determines the Resulting Lymphoma Histology

  Masaharu Tashima; Momoko Nishikori; Wataru Kishimoto; Ryo Yamamoto; Tomomi Sakai; Katsuyuki Ohmori; Shinobu Tsuzuki; Masao Seto; Akifumi Takaori-Kondo

  BLOOD, Nov. 2012

  
• HIV陰性患者に発症しHyper‐CVAD療法が奏功した形質芽球性リンパ腫の1例

  MORI AKANE; ARAI YASUYUKI; NISHIKORI MOMOKO; KITANO TOSHIYUKI; KONDO TADAKAZU; TAKAORI AKIFUMI

  臨床血液, 30 Aug. 2012

  
• リンパ腫診療の基本―最良の治療を選ぶための基礎知識《リンパ腫診断のポイント》染色体検査・FISH・遺伝子検査(サザンブロット・PCR)

  錦織桃子

  内科, 01 Aug. 2012

  
• 血液腫瘍の標準治療2012―非専門医のための生涯教育 MALTリンパ腫

  錦織桃子

  成人病と生活習慣病, 15 Jun. 2012

  
• 慢性甲状腺炎を背景に発症した甲状腺原発Peripheral T‐cell lymphoma7症例の臨床病理学的検討

  NIINO DAISUKE; TSUKASAKI KUNIHIRO; NISHIKORI MOMOKO; IZUMI TOORU; TSUCHIYA KENJI; OSHIMA KOICHI

  日本病理学会会誌, 26 Mar. 2012

  
• 骨髄腫に対するフルダラビンを前処置に用いた同種造血幹細胞移植後の治療成績の検討

  MORI MINAKO; KONDO TADAKAZU; HISHISAWA MASAKATSU; NISHIKORI MOMOKO; MIURA YASUO; YAMASHITA KOHEI; ICHINOHE TATSUO; KADOWAKI NORIMITSU; TAKAORI AKIFUMI

  日本造血細胞移植学会総会プログラム・抄録集, 01 Feb. 2012

  
• 膜性腎症を合併した治療抵抗性血管免疫芽球性T細胞性リンパ腫に対し臍帯血移植を施行した1例

  SAKAMAKI TARO; ISHIYAMA KEN'ICHI; ITO TAKESHI; NISHIKORI MOMOKO; KONDO TADAKAZU; TAKAORI AKIFUMI

  日本造血細胞移植学会総会プログラム・抄録集, 01 Feb. 2012

  
• 膜性腎症を合併した治療抵抗性血管免疫芽球性T細胞性リンパ腫に対し臍帯血移植を施行した1例

  SAKAMAKI TARO; ISHIYAMA KEN'ICHI; ITO TAKESHI; NISHIKORI MOMOKO; KONDO TADAKAZU; TAKAORI AKIFUMI

  臨床血液, 30 Jan. 2012

  
• オリゴクローン性T細胞を伴う濾胞樹状細胞腫瘍と診断した孤立性肝腫瘍の一例

  KISHIMOTO WATARU; NISHIKORI MOMOKO; KONDO TADAKAZU; YODA HIROSHI; HAGA HIRONORI; TAKAORI AKIFUMI

  日本リンパ網内系学会会誌, 10 Jun. 2011

  
• Idiopathic CD4 Lymphocytopenia Due to Loss of Heterozygosity of the Mutant CD2 Gene

  Masaharu Tashima; Momoko Nishikori; Toshio Kitawaki; Masakatsu Hishizawa; Taisuke Izumi; Yayoi Fujiwara; Minako Mori; Kaori Kihara; Katsuyuki Ohmori; Tadakazu Kondo; Takayuki Ishikawa; Akifumi Takaori-Kondo

  BLOOD, Nov. 2010

  
• 腫瘍随伴症候群として小脳失調を伴った濾胞性リンパ腫の一例

  TAJIMA SEIJI; NISHIKORI MOMOKO; FUJIWARA YAYOI; HISHISAWA KAZUMASA; KITANO TOSHIYUKI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI

  日本リンパ網内系学会会誌, 31 May 2010

  
• マントル細胞リンパ腫におけるR‐Hyper CVAD療法

  SHIMAZU HIROSHI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI; UCHIYAMA TATSUKI; SAKAMOTO SOICHIRO; SATO TAKAYUKI; TADA KOHEI; MARUYAMA WATARU; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; HISHISAWA KATAKATSU; KADOWAKI NORIMITSU; KAWABATA HIROSHI; TAKAORI KOJI; YAMASHITA KOHEI; ICHINOHE TATSUO; UCHIYAMA TAKU

  臨床血液, 30 Sep. 2009

  
• 中枢神経原発悪性リンパ腫に対するBonnプロトコールの経験

  TADA KOHEI; KONDO TADAKAZU; NISHIKIORI MOMOKO; HISHIZAWA KAZUMASA; YAMASHITA KOHEI; ICHINOHE TATSUO; ISHIKAWA TAKAYUKI; UCHIYAMA SUGURU

  臨床血液, 30 Sep. 2009

  
• 当院における成人T細胞白血病症例の後方視的解析

  UCHIYAMA TATSUKI; HISHIZAWA MASAKATSU; ISADA JUN'YA; ICHINOHE TATSUO; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; KAWABATA HIROSHI; KADOWAKI NORIMITSU; TAKAORI AKIFUMI; YAMASHITA KOHEI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2009

  
• 当科におけるミニ移植の成績

  KONDO TADAKAZU; ICHINOHE TATSUO; KOBAYASHI MASAYUKI; HISHISAWA KAZUMASA; NISHIKIORI MOMOKO; KAWABATA HIROSHI; KADOWAKI NORIMITSU; TAKAORI KOJI; YAMASHITA KOHEI; ISHIKAWA TAKAYUKI; UCHIYAMA TAKU

  臨床血液, 30 Sep. 2009

  
• 急性前骨髄球性白血病のPETHEMAプロトコールによる治療成績

  SAKAMOTO SOICHIRO; ISHIKAWA TAKAYUKI; YOSHIOKA SATOSHI; HISHISAWA KAZUMASA; NISHIKIORI MOMOKO; KOBAYASHI MASAYUKI; KONDO TADAKAZU; YAMASHITA KOHEI; ICHINOHE TATSUO; KAWABATA HIROSHI; TAKAORI KOJI; KADOWAKI NORIMITSU; UCHIYAMA TAKU

  臨床血液, 30 Sep. 2009

  
• 慢性甲状腺炎を背景に発症した甲状腺T細胞リンパ腫の2例

  TAJIMA SEIJI; NISHIKIORI MOMOKO; YOSHIZAWA AKIHIKO; OMORI KATSUYUKI; ISHIKAWA TAKAYUKI

  日本リンパ網内系学会会誌, 10 Jun. 2009

  
• B Cells with BCL2/IGH Translocation Compose a Distinctive Cell Population That May Serve as a Reservoir of Lymphoma of Germinal Center B-Cell Type

  Tomomi Sakai; Momoko Nishikori; Masaharu Tashima; Ryo Yamamoto; Toshio Kitawaki; Akifumi Takaori-Kondo; Shinobu Tsuzuki; Takashi Uchiyama

  BLOOD, Nov. 2008

  
• 緩和な前処置を用いた同種造血幹細胞移植後の造血器腫瘍再発例の予後に関する検討

  UCHIYAMA TATSUKI; ICHINOHE TATSUO; MARUYAMA WATARU; YAMAMOTO KAZUYO; ISHIGAMI TAKAHIRO; SHINOHARA MASANOBU; SAKAMOTO TAKASHI; FUJITA HARUYUKI; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; HISHIZAWA TAKAMASA; KAWABATA HIROSHI; KADOWAKI NORIMITSU; TAKAORI AKIFUMI; HORI TOSHIYUKI; YAMASHITA KOHEI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• 単一施設における複数回同種移植に関する検討

  MARUYAMA WATARU; ICHINOHE TATSUO; YAMAMOTO KAZUYO; ISHIGAMI TAKAHIRO; UCHIYAMA TATSUKI; SHINOHARA MASANOBU; SAKAMOTO TAKASHI; FUJITA HARUYUKI; HISHIZAWA TAKAMASA; NISHIKIORI MOMOKO; YAMASHITA KOHEI; KONDO TADAKAZU; KAWABATA HIROSHI; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; HORI TOSHIYUKI; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• 当科における治療関連MDS/AML22症例の解析

  FUJITA HARUYUKI; KONDO TADAKAZU; YAMASHITA KOHEI; HISHIZAWA MASAKATSU; NISHIKIORI MOMOKO; KAWABATA HIROSHI; ICHINOHE TATSUO; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• T細胞性リンパ腫症例における末梢血T細胞のPD‐1発現の意義

  YAMAMOTO REI; TAJIMA MASAHARU; NISHIKIORI MOMOKO; SAKAI TOMOMI; HISHIZAWA TAKAMASA; YAMASHITA KOHEI; KONDO TADAKAZU; OMORI KATSUYUKI; SUZUKI TAKAYO; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• 非血縁者間骨髄移植後の非感染性肺合併症:緩和な前処置と従来型前処置の比較

  SHINOHARA MASANOBU; KANDA JUN'YA; ICHINOHE TATSUO; MARUYAMA WATARU; YAMAMOTO KAZUYO; ISHIGAMI TAKAHIRO; UCHIYAMA TATSUKI; SAKAMOTO TAKASHI; FUJITA HARUYUKI; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; HISHIZAWA SHIGEMASA; KAWABATA HIROSHI; KADOWAKI NORIMITSU; TAKAORI AKIFUMI; HORI TOSHIYUKI; YAMASHITA KOHEI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• 臍帯血移植後にdonor cell leukemiaを発症した悪性リンパ腫の1例

  YAMAMOTO KAZUYO; KONDO TADAKAZU; HISHISAWA HOSHO; NISHIKIORI MOMOKO; YAMASHITA KOHEI; ICHINOHE TATSUO; KAWABATA HIROSHI; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; HORI TOSHIYUKI; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• De novo CD5陽性びまん性大細胞型B細胞リンパ腫:120例における詳細な臨床病理学的検討の結果

  YAMAGUCHI MOTOKO; NAKAMURA NAOYA; SUZUKI RITSURO; KAGAMI YOSHIKIYO; OKAMOTO MASATAKA; ICHINOHASAMA RYO; YOSHINO TADASHI; SUZUMIYA JUNJI; MURASE TAKAHIRA; MIURA IKUO; OSHIMA KOICHI; NISHIKIORI MOMOKO; TAMARU JUN'ICHI; TANIWAKI MASAFUMI; HIRANO MASAMI; MORISHIMA YASUO; UEDA RYUZO; SHIKU HIROSHI; NAKAMURA SHIGEO

  臨床血液, 30 Sep. 2008

  
• 移植前血清フェリチン値が造血器腫瘍に対する同種造血幹細胞移植の成績に与える影響の検討

  MIZUMOTO CHISAKI; KANDA JUN'YA; KAWABATA HIROSHI; ICHINOHE TATSUO; HISHIZAWA TAKAMASA; NISHIKIORI MOMOKO; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; YAMASHITA KOHEI; KONDO TADAKAZU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• BCL2転座陽性B細胞の生理学的特徴と分化指向性の解析

  SAKAI TOMOMI; NISHIKIORI MOMOKO; TAJIMA MASAHARU; KITAWAKI TOSHIO; YAMAMOTO REI; TAKAORI AKIFUMI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2008

  
• Characterizing biological features of B cells carrying BcL2/IGH translocation

  T. Sakai; M. Nishikori; T. Kitawaki; M. Tashima; R. Yamamoto; T. Uchiyama

  ANNALS OF ONCOLOGY, Jun. 2008

  
• PD-1/PD-1-ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

  Ryo Yamamoto; Momoko Nishikori; Toshio Kitawaki; Tomomi Sakai; Masakatsti Hishizawa; Malsaharu Tashima; Tadakazu Kondo; Katsuyuki Ohmori; Takashi Uchiyama

  BLOOD, Nov. 2007

  
• BCL2転座陽性B細胞のマウス生体内における動態解析

  SAKAI TOMOMI; NISHIKIORI MOMOKO; YAMAMOTO REI; TAJIMA MASAHARU; KITAWAKI TOSHIO; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2007

  
• 急性骨髄性白血病・ハイリスク骨髄異形成症候群に対する同種造血幹細胞移植の成績に急性GVHDが与える影響

  IO KATSUHIRO; KAMATA JUN'YA; ICHINOHE TATSUO; MATSUI MICHIYUKI; CHONABAYASHI KAZUHISA; ISHIGAMI TAKAHIRO; HISHIZAWA MASAKATSU; NISHIKIORI MOMOKO; KAWABATA HIROSHI; YAMASHITA KOHEI; KONDO TADAKAZU; TAKAORI AKIFUMI; HORI TOSHIYUKI; KADOWAKI NORIMITSU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2007

  
• HTLV‐I陰性成熟T/NK細胞腫瘍に対する同種造血幹細胞移植

  CHONABAYASHI KAZUHISA; ISHIKAWA TAKAYUKI; ICHINOHE TATSUO; IO KATSUHIRO; ISHIGAMI TAKAHIRO; MATSUI MASAYUKI; TAKAO SUMIKO; KONDO TADAKAZU; YAMASHITA KOHEI; HISHIZAWA MASAKATSU; NISHIKIORI MOMOKO; KAWABATA HIROSHI; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; HORI TOSHIYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2007

  
• 緩和な前処置を用いた同種造血幹細胞移植における幹細胞源としての骨髄と末梢血の比較

  MATSUI MICHIYUKI; KANDA JUN'YA; ICHINOHE TATSUO; IO KATSUHIRO; CHONABAYASHI KAZUHISA; ISHIGAMI TAKAHIRO; HISHIZAWA MASAKATSU; NISHIKIORI MOMOKO; KAWABATA HIROSHI; YAMASHITA KOHEI; KONDO TADAKAZU; TAKAORI AKIFUMI; HORI TOSHIYUKI; KADOWAKI NORIMITSU; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2007

  
• ホジキンリンパ腫の微小環境におけるPD‐1‐PD‐1リガンドを介したシグナル機構の意義

  YAMAMOTO REI; NISHIKIORI MOMOKO; SAKAI TOMOMI; TAJIMA MASAHARU; HISHIZAWA MASAKATSU; KONDO TADAKAZU; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2007

  
• T細胞性リンパ腫におけるEBER陽性率と臨床経過・予後についての検討

  TANAKA YASUHIRO; KANDA JUN'YA; MIZUMOTO CHISAKI; TASHIMA MASAHARU; NISHIKIORI MOMOKO; YAMASHITA KOHEI; KONDO TADAKAZU; KAWABATA HIROSHI; ICHINOHE TATSUO; TAKAORI AKIFUMI; KADOWAKI NORIMITSU; HORI TOSHIYUKI; ISHIKAWA TAKAYUKI; UCHIYAMA TAKASHI; TACHIBANA ATSUHIRO; HAGA HIRONORI

  臨床血液, 30 Sep. 2006

  
• リンパ系腫瘍におけるPD‐1リガンドの発現およびその制御機構の解析

  YAMAMOTO RYO; NISHIKOORI MOMOKO; SAKAI TOMOMI; HISHIZAWA MASAKATSU; OMORI KATSUYUKI; SUZUKI TAKAYO; UCHIYAMA TAKASHI

  臨床血液, 30 Sep. 2006

  
• Shared and differential gene expression profiles between anaplastic large cell lymphoma and Hodgkin lymphoma revealed by supervised clustering analyses.

  Y Maesako; M Nishikori; H Ohno; T Uchiyama

  BLOOD, Nov. 2004

  
• 複数の染色体転座を同時に認めたB細胞リンパ腫の臨床像と遺伝子解析

  UETA CHIYOKO; NISHIKIORI MOMOKO; HISHIZAWA MASAKATSU; UCHIYAMA SUGURU; MIYAOKA KAZUKO; ONO HITOSHI

  日本リンパ網内系学会会誌, 10 Jun. 2004

  
• 未分化大細胞型リンパ腫におけるBcl‐3の高発現とCD30/NF‐κBシグナル伝達

  NISHIKIORI MOMOKO; UCHIYAMA SUGURU; HAGA HIRONORI; MAESAKO YOSHITOMO; ONO KIMITSUGU

  日本リンパ網内系学会会誌, 10 Jun. 2004

  
• 未分化大細胞型リンパ腫とホジキンリンパ腫の遺伝子発現プロフィルの類似と相違―supervised clusteringによる解析

  MAESAKO YOSHITOMO; NISHIKIORI MOMOKO; UCHIYAMA TAKU; ONO HITOSHI

  日本リンパ網内系学会会誌, 10 Jun. 2004

  
• Anaplastic large cell lymphoma (ALCL) is characterized by high-level expression of Bcl-3, which is phosphorylated at tyrosine residues.

  M Nishikori; Y Maesako; H Haga; H Ohno; T Uchiyama

  BLOOD, Nov. 2003

  
• Anaplastic large cell lymphoma(ALCL)におけるBCL3の発現こう進の意義

  NISHIKORI MOMOKO; MAESAKO YOSHITOMO; ONO HITOSHI; UCHIYAMA TAKASHI

  臨床血液, 30 Aug. 2003

  
• c‐MYC,BCL2,BCL6転座を同時に認めたびまん性大細胞型B細胞リンパ腫(DLBCL)の遺伝子解析

  UEDA CHIYOKO; NISHIKORI MOMOKO; KITAWAKI TOSHIO; ONO HITOSHI; UCHIYAMA TAKASHI

  臨床血液, 30 Aug. 2003

  
• High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin's disease.

  M Nishikori; Y Maesako; C Ueda; M Kurata; H Ohno; T Uchiyama

  BLOOD, Nov. 2002

  
• Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of histone H4/BCL6 fusion gene leading to altered expression of Bcl-6.

  M Kurata; Y Maesako; C Ueda; M Nishikori; T Akasaka; T Uchiyama; H Ohno

  BLOOD, Nov. 2002

  
• Anaplastic large cell lymphomaにおけるBCL3の発現こう進の意義

  NISHIKIORI MOMOKO; MAESAKO YOSHITOMO; ONO HITOSHI; UCHIYAMA TAKASHI

  日本癌学会総会記事, 25 Aug. 2002

  
• Fludarabine+busulfan+200cGy TBIを前処置に用いた難治性・ハイリスク造血器腫ように対するミニ移植

  KITAWAKI TOSHIO; ICHINOHE TATSUO; HISHIZAWA NORIKATSU; NISHIHARA TOSHIO; UEDA MAKI; YAMADA HIROKO; KOBAYASHI MASAYUKI; NISHIKIORI MOMOKO; UCHIYAMA SUGURU

  臨床血液, 30 Oct. 2001

  

Presentations

• 濾胞性リンパ腫の病態と治療

  錦織 桃子

  第127回日本血液学会東北地方会, 17 Feb. 2019, Invited

  
• Recent advances in the treatment of Hodgkin lymphoma.

  Momoko Nishikori

  第56回日本がん治療学会総会, 19 Oct. 2018

  
• 悪性リンパ腫の治療の新たな方向性

  錦織 桃子

  第109回近畿血液学地方会, 09 Jun. 2018, Invited

  
• 悪性リンパ腫の発症機序を考える

  錦織 桃子

  日本血液学会学術集会, 14 Oct. 2016

  
• B細胞リンパ腫

  錦織 桃子

  第8回 研修医のための血液学セミナー ランチョンセミナー, 10 Jul. 2016, Invited

  
• リンパ節腫脹の鑑別

  錦織 桃子

  第8回 研修医のための血液学セミナー グループケーススタディ, 09 Jul. 2016, Invited

  
• PD-1 Blockade for the Treatment of Lymphoid Malignancies: Its Usefulness and Challenges

  Momoko Nishikori

  The 7th JSH International Symposium, 13 May 2016, Invited

  
• マントル細胞リンパ腫の治療

  錦織 桃子

  Meet the MCL experts in Kanagawa, 15 Apr. 2016, Invited

  
• マントル細胞リンパ腫に関する最近の話題

  錦織 桃子

  第16回 南兵庫臨床血液セミナー, 18 Mar. 2016, Invited

  
• 低悪性度B細胞リンパ腫の病態と治療について

  錦織 桃子

  第4回 トレアキシン研究会（富山）, 29 Jan. 2016, Invited

  
• マウスを用いた悪性リンパ腫へのアプローチ

  錦織 桃子

  第23回 東京リンパ腫研究会, 27 Jan. 2016, Invited

  
• International Symposium for Young Doctors and Students

  Momoko Nishikori

  第53回 日本癌治療学会学術集会, 26 Oct. 2015, Invited

  
• B細胞リンパ腫の形成過程と病態について

  錦織 桃子

  第13回 Osaka Clinical Hematology Conference, 26 Sep. 2015, Invited

  
• 基礎的観点からのマントル細胞リンパ腫へのアプローチ

  錦織 桃子

  トレアキシン Meet the Expert in Hyogo, 04 Sep. 2015, Invited

  
• B細胞リンパ腫

  錦織 桃子

  第７回 研修医のための血液学セミナー ランチョンセミナー, 12 Jul. 2015, Invited

  
• リンパ節腫脹の鑑別

  錦織 桃子

  第７回 研修医のための血液学セミナー グループケーススタディ, 11 Jul. 2015, Invited

  
• 悪性リンパ腫における免疫チェックポイント阻害剤の基礎と臨床

  錦織 桃子

  第55回日本リンパ網内系学会総会 シンポジウム２ 悪性リンパ腫における腫瘍免疫, 10 Jul. 2015, Invited

  
• トレアキシン治療とその有害事象について

  錦織 桃子

  香川県造血器腫瘍セミナー, 19 Jun. 2015, Invited

  
• B細胞リンパ腫の成り立ちを考える

  錦織 桃子

  第69回日本病理学会近畿支部学術集会, 30 May 2015, Invited

  
• 悪性リンパ腫の診断における各種検査の意義について

  錦織 桃子

  近畿地区BDセミナー, 11 Apr. 2015, Invited

  
• 染色体・遺伝子診断の基礎

  錦織 桃子

  日本リンパ網内系学会 第3回研修医、若手医師のためのリンパ腫基本セミナー, 14 Mar. 2015, Invited

  
• Ｂ細胞リンパ腫の病態理解の進歩と今後の課題

  錦織 桃子

  第５回長崎血液疾患エキスパートミーティング, 28 Nov. 2014, Invited

  
• Ｂ細胞リンパ腫の形成過程・病態を考える

  錦織 桃子

  第18回最新血液学レクチャーシリーズ, 03 Oct. 2014, Invited

  
• 悪性リンパ腫の病態と診断・治療

  錦織 桃子

  京都府臨床検査技師会血液講演会, 26 Jul. 2014, Invited

  
• ベンダムスチンに関する話題と適正使用について

  錦織 桃子

  トレアキシン Meet the Expert, 18 Jul. 2014, Invited

  
• リンパ節腫大の鑑別

  錦織 桃子

  第６回研修医のための血液学セミナー, 12 Jul. 2014, Invited

  
• ベンダムスチン治療とその副作用対策

  錦織 桃子

  トレアキシン Meet the Expert, 27 Jun. 2014, Invited

  
• リンパ腫診断入門．2)遺伝子診断入門

  錦織 桃子

  日本リンパ網内系学会 第７回若手医師のためのリンパ腫セミナー, 21 Jun. 2014, Invited

  
• Ｂ細胞性リンパ腫の臨床像と分子病態

  錦織 桃子

  第54回日本リンパ網内系学会総会, 20 Jun. 2014, Invited

  
• 濾胞性リンパ腫の診断と治療

  錦織 桃子

  日本リンパ網内系学会 第２回研修医、若手医師のためのリンパ腫基本セミナー, 29 Mar. 2014, Invited

  
• 低悪性度リンパ腫に関する新たな話題と治療

  錦織 桃子

  京都血液フォーラム, 15 Mar. 2014, Invited

  
• ベンダムスチンの有用性とリスクマネジメント

  錦織 桃子

  トレアキシン Meet the Expert, 11 Mar. 2014, Invited

  
• ベンダムスチン療法のベストマネジメント．皮膚障害・過敏反応

  錦織 桃子

  第75回日本血液学会学術集会 コーポレートセミナー, 13 Oct. 2013, Invited

  
• Ｂ細胞リンパ腫における染色体転座の意義

  錦織 桃子

  第75回日本血液学会学術集会, 11 Oct. 2013, Invited

  
• 低悪性度非ホジキンリンパ腫治療の新展開

  錦織 桃子

  第11回日本臨床腫瘍学会学術集会, 29 Aug. 2013, Invited

  
• Biology, Lymphoma Genomics/Clinico-pathologic Correlations.

  Momoko Nishikori

  Chugai Symposium on Malignant Lymphoma 2013, 03 Aug. 2013, Invited

  
• リンパ節腫大の鑑別

  錦織 桃子

  第５回研修医のための血液学セミナー, 06 Jul. 2013, Invited

  
• 正常リンパ球から悪性リンパ腫に至る過程を考える

  錦織 桃子

  第12回筑後ヘマトロジーセミナー, 12 Jun. 2013, Invited

  
• 悪性リンパ腫の病型決定機構の解明に向けた試み

  錦織 桃子

  第18回湘南セミナー, 06 Jun. 2013, Invited

  
• 悪性リンパ腫の診断と治療

  錦織 桃子

  日本検査血液学会静岡支部学術集会, 23 Mar. 2013, Invited

  
• 低悪性度Ｂ細胞リンパ腫に関する最近の話題

  錦織 桃子

  京都血液フォーラム, 16 Mar. 2013, Invited

  
• 血液疾患の診断と再発所見（悪性リンパ腫）

  錦織 桃子

  第23回近畿臨床検査技師会 形態検査部門（血液検査分野）研修会, 16 Feb. 2013, Invited

  
• マウスを用いたＢ細胞リンパ腫の病態解析

  錦織 桃子

  高感受性悪性腫瘍に対する標準治療確立のための多施設共同研究班、難治性リンパ腫小班, 01 Dec. 2012

  
• マウスを用いた悪性リンパ腫の病態研究

  錦織 桃子

  第１回血液若手セミナー, 03 Nov. 2012, Invited

  
• A murine model for elucidating the mechanism of lymphoma subtype determination.

  Momoko Nishikori

  第72回日本癌学会学術総会, 19 Sep. 2012, Invited

  
• リンパ節腫大の鑑別

  錦織 桃子

  第４回研修医のための血液学セミナー, 30 Jun. 2012

  
• リンパ腫モデルマウスを用いた疾患発症メカニズムの解析

  錦織 桃子

  血液フォーラム21, 29 Jun. 2012, Invited

  
• 悪性リンパ腫の病型決定のメカニズム

  錦織 桃子

  基礎血液懇話会, 12 May 2012, Invited

  

Awards

• Sep. 2004

  Japanese Society of Hematology, encouragement award
• Jul. 2005

  Japanese Society for Lymphoreticular Tissue Research, encouragement award

External funds: Kakenhi

• Establishment of efficacy prediction model and clinical application of novel epigenetic modifiers

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  Momoko Nishikori

  From 01 Apr. 2021, To 31 Mar. 2024, Project Closed

  悪性リンパ腫;EZH2;B細胞リンパ腫;EZH2阻害薬;エピゲノム

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K08392/
• Clarifying the significance of Notch signal activation in B-cell lymphomas

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  Momoko Nishikori

  From 01 Apr. 2018, To 31 Mar. 2021, Project Closed

  悪性リンパ腫;免疫微小環境;免疫逃避機構;B細胞リンパ腫;腫瘍微小環境;T細胞;Notch

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K08324/
• Clarifying the pathogenesis of ABC-DLBCL in a mouse model

  Grant-in-Aid for Scientific Research (C)

  Kyoto University

  Momoko Nishikori

  From 01 Apr. 2015, To 31 Mar. 2018, Project Closed

  悪性リンパ腫;マウスモデル;Ｂ細胞リンパ腫;MyD88;HOIP;NF-kappaB

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K09474/
• Analysis of clonal hierarchy and microenvironment of the tumor developed in the mouse mantle cell lymphoma model

  Grant-in-Aid for Scientific Research (C)

  Kyoto University

  Momoko NISHIKORI

  From 01 Apr. 2012, To 31 Mar. 2015, Project Closed

  悪性リンパ腫;マウスモデル;BCL2;CyclinD1;Cyclin D1

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24591391/
• In vivo characterization of B cells with lymphoma-specific translocat in mice and their potential roles in lymphoma development.

  Grant-in-Aid for Young Scientists (B)

  Kyoto University

  Momoko NISHIKORI

  From 01 Apr. 2008, To 31 Mar. 2010, Project Closed

  染色体転座;BCL2;悪性リンパ腫

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20790673/
• 胚中心B細胞性リンパ腫自然発症マウスの作製と腫瘍微小環境・クローン進展機構の解明

  Grant-in-Aid for Young Scientists (B)

  Kyoto University

  錦織 桃子

  From 01 Apr. 2006, To 31 Mar. 2008, Project Closed

  悪性リンパ腫;BCL2

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18790650/
• AID-dependent genetic alteration mechanism to generate antigen-specific antibodies

  Grant-in-Aid for Specially Promoted Research

  Biological Sciences

  Kyoto University

  Tasuku HONJO

  From 01 Apr. 2005, To 31 Mar. 2010, Project Closed

  クラススイッチ;体細胞突然変異;RNA編集;ウラシルDNAグリコシラーゼ;免疫沈降法;マイクロアレイ法;免役学;抗体;ゲノム;癌

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-17002015/
• LUBACによるTNFRシグナル修飾を利用した悪性リンパ腫の治療研究

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  錦織 桃子

  From 01 Apr. 2024, To 31 Mar. 2027, Granted

  B細胞リンパ腫

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K11558/

Education

Teaching subject(s)

• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical Overview of Medicine G

  C324, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical Overview of Medicine F

  C323, Fall, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical Overview of Medicine D

  C321, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Objective Structured Clinical Examination

  8052, Fall, Faculty of Medicine, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Hematology II

  8050, Fall, Faculty of Medicine, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Immunology II

  8031, Spring, Faculty of Medicine, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Practice of Hematology

  8013, Spring, Faculty of Medicine, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical Overview of Medicine D

  3226, Spring, Faculty of Medicine, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Pathophysiology

  M044, Spring, Graduate School of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical Medicine Lecture

  M458, Spring, Graduate School of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical research and development studies seminar

  M439, Fall, Graduate School of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  The Outline of Host Defense

  3220, Spring, Faculty of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Laboratory medicine practice

  8051, Fall, Faculty of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Hematology I

  8049, Spring, Faculty of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Immunology I

  8014, Fall, Faculty of Medicine, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Special Seminar of Multidisciplinary Medical Sciences

  M456, Year-long, Graduate School of Medicine, 8
• From 01 Apr. 2025, To 31 Mar. 2026

  Learning Clinical Laboratory Medicine in Hospital

  8043, Spring, Faculty of Medicine, 8
• From 01 Apr. 2025, To 31 Mar. 2026

  Clinical research and development studies practice

  M440, Year-long, Graduate School of Medicine, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine G

  C324, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine F

  C323, Fall, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine D

  C321, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine F

  3228, Fall, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine D

  3226, Spring, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Immunology II

  8031, Spring, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Practice of Hematology

  8013, Spring, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Overview of Medicine G

  3229, Spring, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Hematology II

  8050, Fall, Faculty of Medicine, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Medicine Lecture

  M458, Spring, Graduate School of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical research and development studies seminar

  M439, Fall, Graduate School of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Pathophysiology

  M044, Spring, Graduate School of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Hematology

  8012, Spring, Faculty of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  The Outline of Host Defense

  3220, Spring, Faculty of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Laboratory medicine practice

  8051, Fall, Faculty of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Hematology I

  8049, Spring, Faculty of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Immunology I

  8014, Fall, Faculty of Medicine, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Special Seminar of Multidisciplinary Medical Sciences

  M456, Year-long, Graduate School of Medicine, 8
• From 01 Apr. 2024, To 31 Mar. 2025

  Learning Clinical Laboratory Medicine in Hospital

  8043, Fall, Faculty of Medicine, 8
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical research and development studies practice

  M440, Year-long, Graduate School of Medicine, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Practice of Hematology

  8013, Spring, Faculty of Medicine, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Clinical Overview of Medicine G

  3229, Spring, Faculty of Medicine, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Clinical research and development studies seminar

  M439, Fall, Graduate School of Medicine, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Pathophysiology

  M044, Spring, Graduate School of Medicine, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Hematology

  8012, Spring, Faculty of Medicine, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  The Outline of Host Defense

  3220, Spring, Faculty of Medicine, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Learning Clinical Laboratory Medicine in Hospital

  8043, Fall, Faculty of Medicine, 8
• From 01 Apr. 2023, To 31 Mar. 2024

  Special Seminar of Multidisciplinary Medical Sciences

  M456, Year-long, Graduate School of Medicine, 8
• From 01 Apr. 2023, To 31 Mar. 2024

  Clinical research and development studies practice

  M440, Year-long, Graduate School of Medicine, 4

Participation in PhD Defense

• Epithelial development of the urinary collecting system in the human embryo

  SAIZONOU OMOLOTO MARIE ANGE JOELLE, Graduate School of Medicine, Chief Examiner

  25 Nov. 2024
• RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia

  MASUDA TATSUYA, Graduate School of Medicine, Chief Examiner

  25 Mar. 2024

Administration

Faculty management (title, position)

• From 01 Oct. 2024, To 30 Sep. 2025

  医学広報委員会_委員
• From 01 Apr. 2023, To 31 Mar. 2025

  医学図書館運営委員会委員
• From 01 Apr. 2023, To 31 Mar. 2024

  図書委員会委員長
• From 01 Apr. 2013, To 31 Mar. 2014

  動物実験施設運営委員会